SEC EDGAR Filing Information

Form SC 13D/A -- General statement of acquisition of beneficial ownership [amend]

Filing Date Changed: 2009-04-21
Documents: 2

SEC Accession No.
0000928475-09-000186
Filing date: 2009-04-21
Accepted: 2009-04-21 16:57:40

Table of submitted documents:

Seq	Type	Document	Size	Description
1	SC 13D/A	sch13damd7042109.txt	8422
2	EX-99	exhibit1042109.txt	7835

		0000928475-09-000186.txt	18390	Complete submission text file

Filer Information:

AMYLIN PHARMACEUTICALS INC (Subject) (0000881464)
IRS No.: 330266089 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-42168 | Film No.: 09762070
SIC: 2834 Pharmaceutical Preparations

Assistant Director 1

Business Address
9360 TOWNE CENTRE DR
SUITE 110
SAN DIEGO CA 92121
6195522200

Mailing Address
9360 TOWNE CENTRE DR
SUITE 110
SAN DIEGO CA 92121

ICAHN CARL C (Filed by) (0000921669)
IRS No.: 000000000 | State of Incorp.: NY | Fiscal Year End: 1231
Type: SC 13D/A | Act: | Film No.:
SIC: 0000

Business Address
C/O ICAHN ASSOCIATES CORP.
767 FIFTH AVE., SUITE 4700
NEW YORK NY 10153
212-702-4300

Mailing Address
C/O ICAHN ASSOCIATES CORP.
767 FIFTH AVE., SUITE 4700
NEW YORK NY 10153